126 related articles for article (PubMed ID: 12176552)
1. Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients.
van Duijnhoven EM; Christiaans MH; Boots JM; van Hooff JP
Transplant Proc; 2002 Aug; 34(5):1723-5. PubMed ID: 12176552
[No Abstract] [Full Text] [Related]
2. Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.
Hu RH; Lee PH; Tsai MK
Transplant Proc; 2000 Nov; 32(7):1689-92. PubMed ID: 11119894
[No Abstract] [Full Text] [Related]
3. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
[No Abstract] [Full Text] [Related]
4. Pharmacokinetics of tacrolimus in paediatric renal transplant recipients.
Webb NJ; Stevenson PJ; Lewis MA; Postlethwaite RJ; Bradbury MG; Undre N
Transplant Proc; 2002 Aug; 34(5):1948-50. PubMed ID: 12176639
[No Abstract] [Full Text] [Related]
5. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
Braun F; Schütz E; Peters B; Talaulicar R; Grupp C; Undre N; Schäfer A; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 2001 May; 33(3):2127-8. PubMed ID: 11377473
[No Abstract] [Full Text] [Related]
6. Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients.
Jørgensen KA; Povlsen JV; Madsen S; Madsen M; Hansen HE; Pedersen AR; Heinsvig EM; Poulsen JH
Transplant Proc; 2002 Aug; 34(5):1721-2. PubMed ID: 12176551
[No Abstract] [Full Text] [Related]
7. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.
Undre NA; Schäfer A
Transplant Proc; 1998 Jun; 30(4):1261-3. PubMed ID: 9636512
[No Abstract] [Full Text] [Related]
8. Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients.
Sifontis NM; Benedetti E; Vasquez EM
Transplant Proc; 2002 Aug; 34(5):1730-2. PubMed ID: 12176554
[No Abstract] [Full Text] [Related]
9. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.
Hesse CJ; Baan CC; Balk AH; Metselaar HJ; Weimar W; van Gelder T
Transplant Proc; 2002 Nov; 34(7):2988-90. PubMed ID: 12431679
[No Abstract] [Full Text] [Related]
10. The effect of breakfast on the oral bioavailability of tacrolimus in diabetic and nondiabetic patients before transplantation.
van Duijnhoven E; Christiaans M; Undre N; Stevenson P; van Hooff J
Transplant Proc; 1998 Jun; 30(4):1268-70. PubMed ID: 9636515
[No Abstract] [Full Text] [Related]
11. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549
[TBL] [Abstract][Full Text] [Related]
12. Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression.
Khoury N; Kriaa F; Hiesse C; Von Ey F; Durbach A; Ammor M; Hafi A; Djeffal R; Boubenider S; Droupy S; Hammoudi Y; Eschwege P; Benoît G; Charpentier B
Transplant Proc; 2000 Dec; 32(8):2763-4. PubMed ID: 11134791
[No Abstract] [Full Text] [Related]
13. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
Uchida K; Tominaga Y; Haba T; Katayama T; Matsuoka S; Sato T; Goto N; Takeda A; Morozumi K; Takagi H
Transplant Proc; 2002 Aug; 34(5):1736-7. PubMed ID: 12176556
[No Abstract] [Full Text] [Related]
14. Demographic considerations in tacrolimus pharmacokinetics.
Fitzsimmons WE; Bekersky I; Dressler D; Raye K; Hodosh E; Mekki Q
Transplant Proc; 1998 Jun; 30(4):1359-64. PubMed ID: 9636552
[No Abstract] [Full Text] [Related]
15. Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.
van Duijnhoven E; Christiaans M; Schäfer A; Undre N; van Hooff J
Transplant Proc; 1998 Jun; 30(4):1266-7. PubMed ID: 9636514
[No Abstract] [Full Text] [Related]
16. Tacrolimus trough level adjustment after administration of fluconazole to kidney recipients.
Toda F; Tanabe K; Ito S; Shinmura H; Tokumoto T; Ishida H; Toma H
Transplant Proc; 2002 Aug; 34(5):1733-5. PubMed ID: 12176555
[No Abstract] [Full Text] [Related]
17. Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation.
Jiménez O; Campistol JM; Vidal E; Faura A; Oppenheimer F; Corbella J; Brunet M
Transplant Proc; 2003 Aug; 35(5):1686-8. PubMed ID: 12962758
[No Abstract] [Full Text] [Related]
18. Medium-term outcome using sirolimus-tacrolimus combination in adult renal transplant recipients.
Rashid I; El-Sabrout R; Butt F; Delaney V; Qadir M; Hanson P; Butt K
Transplant Proc; 2002 Aug; 34(5):1649-50. PubMed ID: 12176520
[No Abstract] [Full Text] [Related]
19. Long-term outcome of tacrolimus rescue therapy in late rejection after renal transplantation.
Budde K; Smettan S; Fritsche L; Waiser J; Giessing M; Kunz R; Türk I; Bauer S; Mai I; Neumayer HH
Transplant Proc; 1998 Aug; 30(5):1780-1. PubMed ID: 9723280
[No Abstract] [Full Text] [Related]
20. Japanese study of FK 506 on kidney transplantation: 2. Follow-up study of FK 506-treated patients.
Transpl Int; 1992; 5 Suppl 1():S552-5. PubMed ID: 14621874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
